Drug Shortage Report for TWYNSTA

Last updated on 2020-01-04 History
Report ID 100134
Drug Identification Number 02371022
Brand name TWYNSTA
Common or Proper name Twynsta
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) AMLODIPINE TELMISARTAN
Strength(s) 5MG 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28's
ATC code C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-12-03
Estimated end date 2020-01-06
Actual end date 2020-01-03
Shortage status Resolved
Updated date 2020-01-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-01-04 English Compare
v6 2020-01-03 English Compare
v5 2020-01-03 French Compare
v4 2020-01-03 English Compare
v3 2019-12-04 English Compare
v2 2019-12-03 French Compare
v1 2019-12-03 English Compare

Showing 1 to 7 of 7